Print “PDF version”
The COVID-19
pandemic has had a significant impact on hospital infections. In our October
2021 What's New in the Patient Safety World column “HAI’s Increase During
COVID-19 Pandemic” we noted
that during the pandemic there were significant national increases in CLABSI’s (central
line–associated bloodstream infections), CAUTI’s (catheter-associated urinary
tract infections), VAE’s (ventilator-associated events), and MRSA infections.
In addition, there has been a substantial increase in antimicrobial resistance since the pandemic began. CDC (CDC 2022) reports that resistant hospital-onset infections and deaths both increased at least 15% from 2019 to 2020 among seven pathogens:
Antifungal-resistant
threats rose in 2020, too, including Candida auris
(60% increase) and other Candida species (26% increase) in infections in
hospitals.
During the first year
of the pandemic, more than 29,400 people died from antimicrobial-resistant
infections commonly associated with healthcare. Of these, nearly 40% of the
people got the infection while they were in the hospital.
CDC notes that
hospitals treated sicker patients who required more frequent and longer use of
medical devices like catheters and ventilators. Hospitals also experienced
personal protective equipment supply challenges, staffing shortages, and longer
patient visits.
CDC hopes that the
trend is temporary but notes we must invest in the prevention-focused public
health actions that we know work, such as accurate laboratory detection, rapid
response and containment, effective infection prevention and control, and
expansion of innovative strategies to combat antimicrobial resistance. Those
strategies include alternatives to antibiotics and antifungals, new vaccines to
combat infections that can develop antimicrobial resistance, and novel
decolonizing agents to stop the spread of antimicrobial-resistant germs by
people who may not know they are carriers.
Some of our prior columns on antibiotic stewardship:
See also our other
columns related to COVID-19:
References:
CDC (Centers for Disease Control and Prevention). COVID-19. U.S. Impact on Antimicrobial Resistance. 2022 Special Report. CDC 2022
https://www.cdc.gov/drugresistance/covid19.html
Print “PDF version”
http://www.patientsafetysolutions.com/
What’s New in
the Patient Safety World Archive